Transcription factor E2F-1 has a putative consensus sequence for phosp
horylation by cyclin dependent kinase (Ser-Pro-X-Lys/Arg). Therefore,
we studied the phosphorylation of E2F-1 in vivo and in vitro and its b
iological functions. E2F-1 was prepared by immunoprecipitation with an
ti-E2F-1 antibody from IMR32 lysates and was effectively phosphorylate
d by human cyclin A-cdk2 which was expressed in insect cells using bac
ulovirus system. GST-EZF-1 was phosphorylated by cyclin A-cdk2 more ef
ficiently than by cyclin E-cdk2. Cyclin D1-cdk4 phosphorylated PRE but
scarcely phosphorylated GST-E2F-1 or H1 histone. The 60 kd protein pr
ecipitated with anti-E2F-1 antibody was phosphorylated in vivo. Phosph
o-peptide mapping indicated that its cleavage profile was identical wi
th that of E2F-1 phosphorylated by cyclin A-cdk2 in vitro. This 60 kd
protein, which is likely to be E2F-1, was not phosphorylated during th
e GO and early G1 phase, Phosphorylation of E2F-1 began from the S pha
se while phosphorylation of pRB started nearly at G1/S. The in vivo ph
osphorylation of E2F-1 was inhibited by butyrolactone I, a cyclin-depe
ndent kinase inhibitor (Kitagawa et al., 1993, Oncogene, 8, 2425-2432)
. The binding of E2F-1 to E2 promoter was found to be reduced by phosp
horylation of E2F-1 by cyclin A-cdk2, suggesting that phosphorylation
of E2F-1 may induce shut off of gene expression at the transcriptional
level. These results suggest that E2F-1 is phosphorylated by cyclin A
-cdkZ in the S phase in vivo as well as in vitro and that its phosphor
ylation by cyclin A-cdkZ may modulate its activity.